Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort

BACKGROUND/AIMS: 17β-hydroxysteroid dehydrogenase 13 (HSD17B13) variants were recently reported to have significantly lower odds of non-alcoholic fatty liver disease (NAFLD). This is a two-part study that aimed to evaluate the association of HSD17B13 variants with NAFLD and its histological severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Yi-Wen, Kong, Amanda Shen-Yee, Zain, Shamsul Mohd, Chan, Wah-Kheong, Tan, Hwa-Li, Mohamed, Zahurin, Pung, Yuh-Fen, Mohamed, Rosmawati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273635/
https://www.ncbi.nlm.nih.gov/pubmed/33618508
http://dx.doi.org/10.3350/cmh.2020.0162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273635/
https://www.ncbi.nlm.nih.gov/pubmed/33618508
http://dx.doi.org/10.3350/cmh.2020.0162

Ejemplares similares